Skip to content

Strategies and mechanisms of rapid relief of suicidal ideation in patients with depression by neuro-directional navigational transcranial magnetic stimulation

Strategies and mechanisms of rapid relief of suicidal ideation in patients with depression by neuro-directional navigational transcranial magnetic stimulation

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055320
Enrollment
Unknown
Registered
2022-01-06
Start date
2021-12-01
Completion date
Unknown
Last updated
2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment resistant depression

Interventions

iTBS group:Use of transcranial magnetic stimulation (TMS) iTBS in the treatment of patients with depression
cTBS group:Use of transcranial magnetic stimulation (TMS) cTBS in the treatment of patients with depression
Healthy controls:Healthy subjects with matched gender, age and education level were selected as the control group, and the exclusion criteria were the same as the depression group. General demographic

Sponsors

Wenzhou Seventh People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
13 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. This episode meets the diagnostic criteria of DSM-5 major depression, is not accompanied by psychotic symptoms, and is ineffective after at least one antidepressant treatment for one month; 2. The total score of the 24-item Hamilton Depression Scale (HAMD-24) is >=20, the third item of HAMD-24 is >= 3 and the total score of the Baker Suicidal Ideation Scale is >=12; 3. Han nationality, right-handed; 4. Junior high school education level or above; 5. Aged between 13-45 years.

Exclusion criteria

Exclusion criteria: 1. Epilepsy patients, patients with metal objects in the body and patients with acute cerebrovascular accident; 2. A history of alcohol or drug abuse or dependence; 3. Patients with organic mental disorders and mental retardation; 4. Patients who received electroconvulsive shock without convulsions in the past or three months; 5. Patients with severe neurological, heart, liver and kidney, endocrine, blood system and other physical diseases or diseases that may interfere with the evaluation of the test.

Design outcomes

Primary

MeasureTime frame
Hamilton Depression Scale;Hamilton Anxiety Scale;Beck Scale of Suicidal Ideation;Sneth Hamilton Pleasure Scale;Columbia Suicide Severity Rating Scale;

Secondary

MeasureTime frame
Motivation and Energy Inventory;EEG;TMS-EEG;MRI;

Countries

China

Contacts

Public ContactLuan Honglin

Wenzhou Seventh People's Hospital

luanhonglin0314@163.com+86 137 7745 8752

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Apr 23, 2026